APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL
Publication
, Conference
Hijazi, Z; Alexander, JH; Li, Z; Wojdyla, D; Mehran, R; Granger, CB; Bahit, MC; Windecker, S; Berwanger, O; Halvorsen, S; Sinnaeve, P ...
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
March 24, 2020
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
March 24, 2020
Volume
75
Issue
11
Start / End Page
298 / 298
Location
Chicago, IL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hijazi, Z., Alexander, J. H., Li, Z., Wojdyla, D., Mehran, R., Granger, C. B., … Lopes, R. (2020). APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 75, pp. 298–298). Chicago, IL: ELSEVIER SCIENCE INC.
Hijazi, Ziad, John H. Alexander, Zhuokai Li, Daniel Wojdyla, Roxana Mehran, Christopher B. Granger, M Cecilia Bahit, et al. “APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75:298–298. ELSEVIER SCIENCE INC, 2020.
Hijazi Z, Alexander JH, Li Z, Wojdyla D, Mehran R, Granger CB, et al. APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2020. p. 298–298.
Hijazi, Ziad, et al. “APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 75, no. 11, ELSEVIER SCIENCE INC, 2020, pp. 298–298.
Hijazi Z, Alexander JH, Li Z, Wojdyla D, Mehran R, Granger CB, Bahit MC, Windecker S, Berwanger O, Halvorsen S, Sinnaeve P, Storey R, Lopes R. APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2020. p. 298–298.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
March 24, 2020
Volume
75
Issue
11
Start / End Page
298 / 298
Location
Chicago, IL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology